Cristalli Maria Paola, La Monaca Gerardo, De Angelis Chiara, Pranno Nicola, Annibali Susanna
Department of Biotechnologies and Medical Surgical Sciences, Sapienza University of Rome, Rome, Italy.
Department of Sense Organs, Sapienza University of Rome, Rome, Italy.
Pain Res Manag. 2017;2017:9246352. doi: 10.1155/2017/9246352. Epub 2017 Feb 23.
. The aim of this study was to determine the effectiveness of preoperative administration of single-dose of paracetamol-codeine, in the relieving of acute postoperative pain after the surgical removal of an impacted mandibular third molar. . The study cohort consisted of 32 Caucasian outpatients, giving a total of 64 bilateral symmetrical impacted mandibles. Patients were randomized in two experimental groups to receive a preoperative oral dose of paracetamol-codeine (analgesic group) or a placebo (placebo group) at the first and second surgeries. Study participants were asked to record pain intensity scores during the operation and the next 2 days, the time of the first request for rescue analgesic, and the total number of postoperative-supplement paracetamol-codeine tablets. . The pain intensity score on the first day was significantly lower in the analgesic group than in the placebo group ( < 0.001). The time to using rescue therapy was significantly longer in the analgesic group than in the placebo group ( = 0.004). The number of paracetamol-codeine tablets used postoperatively did not differ between the analgesic and placebo groups ( = 0.104). . Preoperative paracetamol-codeine is effective in providing immediate postoperative pain control after third molar surgery and in delaying the initial onset of pain. This trial is registered with ClinicalTrials.gov Identifier (Registration Number): NCT03049878.
本研究的目的是确定术前单次给予对乙酰氨基酚 - 可待因在缓解下颌阻生第三磨牙手术后急性疼痛方面的有效性。研究队列由32名白种人门诊患者组成,共有64个双侧对称的阻生下颌骨。患者被随机分为两个实验组,在第一次和第二次手术前分别接受口服对乙酰氨基酚 - 可待因(镇痛组)或安慰剂(安慰剂组)。要求研究参与者记录手术期间及接下来2天的疼痛强度评分、首次请求使用解救镇痛药的时间以及术后补充对乙酰氨基酚 - 可待因片的总数。镇痛组第一天的疼痛强度评分显著低于安慰剂组(<0.001)。镇痛组使用解救治疗的时间显著长于安慰剂组(=0.004)。镇痛组和安慰剂组术后使用对乙酰氨基酚 - 可待因片的数量没有差异(=0.104)。术前对乙酰氨基酚 - 可待因在提供第三磨牙手术后即时的术后疼痛控制以及延迟疼痛的初始发作方面是有效的。本试验已在ClinicalTrials.gov上注册,标识符(注册号):NCT03049878。